CSF or serum neurofilament light added to α‐Synuclein panel discriminates Parkinson's from controls

BACKGROUND: Neurofilament light chain is a marker of axonal damage and is of interest as a biofluid biomarker for PD. The objective of this study was to investigate whether CSF or serum neurofilament contributes to a combination of CSF biomarkers in defining the optimal biomarker panel for discrimin...

Descripción completa

Detalles Bibliográficos
Autores principales: Oosterveld, Linda P., Verberk, Inge M.W., Majbour, Nour K., El‐Agnaf, Omar M., Weinstein, Henry C., Berendse, Henk W., Teunissen, Charlotte E., van de Berg, Wilma D.J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027879/
https://www.ncbi.nlm.nih.gov/pubmed/31737952
http://dx.doi.org/10.1002/mds.27897

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027879/
https://www.ncbi.nlm.nih.gov/pubmed/31737952
http://dx.doi.org/10.1002/mds.27897

Ejemplares similares